Metraipolis › archive › dc_99718d3bf35e
Post-translational protein lactylation modification in lung cancer: an emerging targeted therapeutic strategy — Europe PMC PMID:41890749
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41890749
- DOI
- 10.3389/fimmu.2026.1734414
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T13:08:46.464Z
- SHA-256 of the archived text
bb97c274e6f05410fb7f1aa037d73a78f3dcf611b6dc7418a4c9343c3032e3c9- Stable URL of this page
https://metraipolis.com/documento/dc_99718d3bf35e
How to cite
Post-translational protein lactylation modification in lung cancer: an emerging targeted therapeutic strategy — Europe PMC PMID:41890749 — Europe PMC (en), https://europepmc.org/article/MED/41890749 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99718d3bf35e (Metraipolis archive dc_99718d3bf35e, sha256 bb97c274e6f05410fb7f1aa037d73a78f3dcf611b6dc7418a4c9343c3032e3c9)
BibTeX
@misc{dc99718d3bf35e,
title = {Post-translational protein lactylation modification in lung cancer: an emerging targeted therapeutic strategy — Europe PMC PMID:41890749},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41890749},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99718d3bf35e; sha256 bb97c274e6f05410fb7f1aa037d73a78f3dcf611b6dc7418a4c9343c3032e3c9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41890749. Agents can read the archived copy with the MCP tool read_document.